Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Clinuvel Analyses From U.S. Study Show ‘Dramatic Improvement’

Nov. 3 (Bloomberg) -- Clinuvel Pharmaceuticals Ltd. said analyses of its Phase II U.S. study in EPP has shown patients who recieved the active drug were able to spend more time in direct sunlight.

Link to Statement:{NSN LU2RW43PR6RK <GO>}

Link to Company News:{CUV AU <Equity> CN <GO>}

To contact the editor responsible for this story: Malcolm Scott at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.